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Introduction
The development of autoimmune diseases involves a breakdown in the mechanisms that control self reactive lymphocytes. The primary mechanism that generally maintains self tolerance is thymic deletion of autoreactive T cells with high affinity for self-antigens.
However, this mechanism is not perfect and autoreactive T cells do escape to the periphery.
Recent data suggest that in addition to the mechanisms of clonal deletion and anergy, regulatory T cells play a significant role in the generation and maintenance of peripheral tolerance. Indeed, there is compelling evidence that immune responsiveness is controlled by a sub-population of regulatory T (T reg) cells that are enriched in the naturally activated subset of CD4 T cells, and which constitutively express the CD25 (IL-2R ) molecule. The thymus is a primary source of this regulatory CD4 + CD25 + T cell (Treg) subset, which participates in the active suppression of potentially autoreactive T cells in the periphery 1, 2 . CD4 + CD25 + Treg cells have been described in a variety of experimental systems to provide protection from T cell-mediated autoimmune disorders (reviewed in 3 ) . This Treg population has been also isolated from human thymus 4, 5 and the peripheral blood of healthy subjects [6] [7] [8] . Similar to murine CD25 + T cells 9 , they are naturally anergic in vitro and they inhibit the proliferation of co-cultured conventional CD4 + CD25 -T cells in a contact-dependent manner. The possible role of the surface molecules, CTLA-4 and TGF-, in the regulatory function of CD25 + Treg cells is controversial and their mechanisms of suppression remain to be determined 3 .
The forkhead transcription factor, Foxp3, was reported recently to be essential for the development and functional activity of mice and human CD25 + Treg cells [10] [11] [12] [13] . Moreover, 17 . In contrast, the CD4 + CD25 + T cell subset was shown to be enriched with functionally active regulatory cells in the inflamed joints of patients with rheumatoid arthritis 18 . The deficiency in numbers of CD4 + CD25 + T cells was reported in the PBL of patients with virus associated autoimmunity hepatitis C-mixed cryoglobulinemia vasculitis, whereas suppressive activity of Treg was not changed 19 . Therefore, additional studies are required to clarify the involvement of these cells in autoimmune diseases.
In the present study, we analysed thymuses derived from Myasthenia Gravis (MG) patients in an attempt to identify possible quantitative and/or qualitative defects in the regulatory T cell population. Myasthenia Gravis is a prototypical CD4 + T cell-dependent autoimmune disease mediated by anti-acetylcholine receptor (AChR) autoantibodies 20 . The anti-AChR antibodies affecting the neuromuscular transmission are found in more than 85% of patients. This autoimmune disorder is the only disease in which the thymus is believed to be the initiation organ of pathogenesis, and thymic ablation is a common therapy for many patients 21 , making available thymic samples. MG is also characterized by a high incidence of morphological thymic abnormalities 22 . More than half of patients, especially young females with high titer of anti-AChR antibodies, present with thymic hyperplasia, characterized by numerous lymphoid follicles with germinal centers similar to those found in lymph nodes 23 .
The hyperplastic MG thymus contains activated anti-AChR autoreactive T cells 24-28 and antiAChR antibody producing B cells 29 . AChR expression has been demonstrated in both normal and MG thymuses, enabling efficient autoantigen presentation [30] [31] [32] . All together, these points strongly argue that the hyperplastic thymus is the effector site of the autoantibody response in
MG.
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The The expression of the transcription factor Foxp3 was shown to be necessary and sufficient for Treg cell generation and function in mice and in healthy humans [10] [11] [12] [13] 45 .
In conclusion, we demonstrate for the first time a functional defect of regulatory thymic cells that could explain the loss of self-tolerance in human autoimmune Myasthenia Gravis.
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